AprilBio Co Eulerpool News

AprilBio Co Stock News

AprilBio Co is being monitored by journalists and investors worldwide. We gather the latest AprilBio Co news here.

AprilBio Co Stock Press Releases

AprilBio Co regularly publishes news on the company's website that are relevant for investors.

AprilBio Co News 2026

This page contains all current news, analysis and press releases for AprilBio Co stock (397030.KQ, ISIN: KR7397030008). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at AprilBio Co.

AprilBio Co Stock

AprilBio Co AprilBio Co Ltd, headquartered in Chuncheon, South Korea, operates in the Health Care sector, specializing in biotechnology. The company focuses on developing long-acting proteins and antibody drugs, primarily engaged in R&D for innovative biopharmaceuticals including antibody therapeutics and long-acting recombinant protein pharmaceuticals. Listed on July 28, 2022, it employs 24 full-time staff in its research and development activities.